Stocktoria
China Life Insurance Company Limited 601628.SS
CN · Shanghai Stock Exchange · XSHG · stock · Financial Services · website
China Life Insurance Company Limited financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | CN¥605.1B | CN¥302.9B | CN¥396.5B | CN¥822.3B |
| SG&A expense | CN¥8.1B | CN¥7.4B | CN¥6.3B | CN¥42.2B |
| Interest expense | — | — | — | CN¥4.9B |
| Income tax | CN¥25.1B | CN¥6.3B | -CN¥719.0M | -CN¥9.5B |
| Net income | CN¥154.1B | CN¥106.9B | CN¥51.2B | CN¥32.1B |
| EPS (diluted) | CN¥5.45 | CN¥3.78 | CN¥1.81 | CN¥1.14 |
| Operating cash flow | CN¥459.9B | CN¥378.8B | CN¥384.4B | CN¥352.0B |
| Free cash flow | CN¥456.9B | CN¥374.8B | CN¥380.2B | CN¥348.9B |
| Cash & equivalents | CN¥143.3B | CN¥86.5B | CN¥150.5B | CN¥129.0B |
| Total assets | CN¥7.59T | CN¥6.77T | CN¥5.65T | CN¥5.25T |
| Total liabilities | CN¥6.98T | CN¥6.25T | CN¥5.32T | CN¥4.81T |
| Shareholders' equity | CN¥595.2B | CN¥509.7B | CN¥327.8B | CN¥436.2B |
Growth · year-over-year · Revenue CAGR -9.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +99.8% | -23.6% | -51.8% | — |
| Net income growth | +44.1% | +108.9% | +59.5% | — |
| EPS growth | +44.2% | +108.8% | +58.8% | — |
| Free cash flow growth | +21.9% | -1.4% | +9.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · CN · as of 2025-12-31. Figures in CNY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.